Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure. uri icon

Overview

publication date

  • November 18, 2025

Identity

PubMed Central ID

  • PMC12626236

Digital Object Identifier (DOI)

  • 10.1002/hem3.70253

PubMed ID

  • 41262124

Additional Document Info

volume

  • 9

issue

  • 11